- $2.44bn
 - $2.43bn
 - $782.12m
 
- 84
 - 60
 - 88
 - 92
 
Annual balance sheet for ACM Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | USG | USG | USG | USG | USG | 
| Status: | Final | Final | Final | Final | Final | 
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 100 | 593 | 339 | 284 | 444 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 66.1 | 126 | 213 | 323 | 429 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 261 | 953 | 964 | 1,176 | 1,483 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 12.5 | 18.2 | 85.4 | 209 | 283 | 
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 341 | 1,052 | 1,236 | 1,491 | 1,856 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 103 | 206 | 396 | 501 | 641 | 
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 200 | 376 | 561 | 724 | 951 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 141 | 676 | 675 | 767 | 905 | 
| Total Liabilities & Shareholders' Equity | 341 | 1,052 | 1,236 | 1,491 | 1,856 | 
| Total Common Shares Outstanding |